fMRI connectivity as a biomarker of antipsychotic treatment response: A systematic review
- PMID: 37797435
- PMCID: PMC10568423
- DOI: 10.1016/j.nicl.2023.103515
fMRI connectivity as a biomarker of antipsychotic treatment response: A systematic review
Abstract
Background: Antipsychotic drugs are the first-choice therapy for psychotic episodes, but antipsychotic treatment response (AP-R) is unpredictable and only becomes clear after weeks of therapy. A biomarker for AP-R is currently unavailable. We reviewed the evidence for the hypothesis that functional magnetic resonance imaging functional connectivity (fMRI-FC) is a predictor of AP-R or could serve as a biomarker for AP-R in psychosis.
Method: A systematic review of longitudinal fMRI studies examining the predictive performance and relationship between FC and AP-R was performed following PRISMA guidelines. Technical and clinical aspects were critically assessed for the retrieved studies. We addressed three questions: Q1) is baseline fMRI-FC related to subsequent AP-R; Q2) is AP-R related to a change in fMRI-FC; and Q3) can baseline fMRI-FC predict subsequent AP-R?
Results: In total, 28 articles were included. Most studies were of good quality. fMRI-FC analysis pipelines included seed-based-, independent component- / canonical correlation analysis, network-based statistics, and graph-theoretical approaches. We found high heterogeneity in methodological approaches and results. For Q1 (N = 17) and Q2 (N = 18), the most consistent evidence was found for FC between the striatum and ventral attention network as a potential biomarker of AP-R. For Q3 (N = 9) accuracy's varied form 50 till 93%, and prediction models were based on FC between various brain regions.
Conclusion: The current fMRI-FC literature on AP-R is hampered by heterogeneity of methodological approaches. Methodological uniformity and further improvement of the reliability and validity of fMRI connectivity analysis is needed before fMRI-FC analysis can have a place in clinical applications of antipsychotic treatment.
Keywords: Antipsychotic response; Functional connectivity; Prediction; Psychosis; fMRI.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- American Psychiatric Association, editor. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 2013.
-
- Anon. WHO ATC/DDD Index 2020. WHO Collaborating Centre for Drugs Statistics Methodology.
-
- Anticevic A., Hu X., Xiao Y., Hu J., Li F., Bi F., Cole M.W., Savic A., Yang G.J., Repovs G., Murray J.D., Wang X.-J., Huang X., Lui S.u., Krystal J.H., Gong Q. Early-course unmedicated schizophrenia patients exhibit elevated prefrontal connectivity associated with longitudinal change. J. Neurosci. 2015;35(1):267–286. - PMC - PubMed
-
- Birn R.M., Diamond J.B., Smith M.A., Bandettini P.A. Separating respiratory-variation-related fluctuations from neuronal-activity-related fluctuations in fMRI. Neuroimage. 2006;31(4):1536–1548. - PubMed
Further reading
-
- Olanzapine 2.5 mg tablets - Summary of Product Characteristics (SmPC) - (emc). Accessed September 8, 2021. https://www.medicines.org.uk/emc/product/3097/smpc#gref.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
